JP2022550072A5 - - Google Patents
Info
- Publication number
- JP2022550072A5 JP2022550072A5 JP2022519181A JP2022519181A JP2022550072A5 JP 2022550072 A5 JP2022550072 A5 JP 2022550072A5 JP 2022519181 A JP2022519181 A JP 2022519181A JP 2022519181 A JP2022519181 A JP 2022519181A JP 2022550072 A5 JP2022550072 A5 JP 2022550072A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pi4kiiiα
- fam126
- ttc7
- haloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2019108548 | 2019-09-27 | ||
| CNPCT/CN2019/108548 | 2019-09-27 | ||
| CN202011009274.9 | 2020-09-23 | ||
| CN202011009274 | 2020-09-23 | ||
| PCT/CN2020/118044 WO2021057955A1 (zh) | 2019-09-27 | 2020-09-27 | 一种治疗心境障碍的方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022550072A JP2022550072A (ja) | 2022-11-30 |
| JP2022550072A5 true JP2022550072A5 (https=) | 2023-10-10 |
Family
ID=75165596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022519181A Pending JP2022550072A (ja) | 2019-09-27 | 2020-09-27 | 気分障害を処置するための方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220362203A1 (https=) |
| EP (1) | EP4043013A4 (https=) |
| JP (1) | JP2022550072A (https=) |
| KR (1) | KR20220122972A (https=) |
| CN (2) | CN119524127A (https=) |
| AU (1) | AU2020352345A1 (https=) |
| BR (1) | BR112022005855A2 (https=) |
| CA (1) | CA3154723A1 (https=) |
| IL (1) | IL291639A (https=) |
| MX (1) | MX2022003720A (https=) |
| PH (1) | PH12022550572A1 (https=) |
| TW (1) | TW202126295A (https=) |
| WO (1) | WO2021057955A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024537837A (ja) * | 2021-09-30 | 2024-10-16 | ヌオ－ベータ・ファーマシューティカル・テクノロジー（シャンハイ）カンパニー・リミテッド | ハロゲン化フェニルアルシンオキシド化合物およびその用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1621554T4 (da) | 1992-08-21 | 2012-12-17 | Univ Bruxelles | Immunoglobuliner blottet for lette kæder |
| US6005079A (en) | 1992-08-21 | 1999-12-21 | Vrije Universiteit Brussels | Immunoglobulins devoid of light chains |
| ES2162863T3 (es) | 1993-04-29 | 2002-01-16 | Unilever Nv | Produccion de anticuerpos o fragmentos (funcionalizados) de los mismos derivados de inmunoglobulinas de cadena pesada de camelidae. |
| GB0020351D0 (en) * | 2000-08-17 | 2000-10-04 | Catalyst Biomedica Ltd | Treatment of hyperproliferative diseases |
| GB2460976B (en) * | 2005-03-24 | 2010-02-17 | John Marcell Davis | Methods of determining compounds useful in the treatment of bipolar disorder and methods of treating such disorders |
| WO2016172952A1 (zh) * | 2015-04-30 | 2016-11-03 | 江苏挪贝肽医药科技有限公司 | PI4KIIIα蛋白及相关的膜蛋白复合体在治疗阿尔茨海默病中的应用 |
| JP6636614B2 (ja) * | 2015-04-30 | 2020-01-29 | ジャンスー・ヌオ−ベータ・ファーマシューティカル・テクノロジー・カンパニー・リミテッド | アルツハイマー病の治療に用いられる薬物および治療標的のスクリーニング方法 |
| CN108721621B (zh) * | 2017-04-14 | 2022-03-01 | 中国科学院上海高等研究院 | 抑制肝纤维化的小分子化合物及应用 |
| CN109966281B (zh) * | 2019-04-11 | 2021-04-27 | 北京大学 | PAO作为Pi4KIIα抑制剂在制备治疗创伤后应激障碍药物中的应用 |
-
2020
- 2020-09-25 TW TW109133409A patent/TW202126295A/zh unknown
- 2020-09-27 JP JP2022519181A patent/JP2022550072A/ja active Pending
- 2020-09-27 CN CN202410709814.6A patent/CN119524127A/zh active Pending
- 2020-09-27 KR KR1020227014142A patent/KR20220122972A/ko active Pending
- 2020-09-27 MX MX2022003720A patent/MX2022003720A/es unknown
- 2020-09-27 EP EP20869531.2A patent/EP4043013A4/en active Pending
- 2020-09-27 PH PH1/2022/550572A patent/PH12022550572A1/en unknown
- 2020-09-27 US US17/763,662 patent/US20220362203A1/en not_active Abandoned
- 2020-09-27 BR BR112022005855A patent/BR112022005855A2/pt not_active Application Discontinuation
- 2020-09-27 CA CA3154723A patent/CA3154723A1/en active Pending
- 2020-09-27 WO PCT/CN2020/118044 patent/WO2021057955A1/zh not_active Ceased
- 2020-09-27 AU AU2020352345A patent/AU2020352345A1/en not_active Abandoned
- 2020-09-27 CN CN202080067722.2A patent/CN114450003B/zh active Active
-
2022
- 2022-03-23 IL IL291639A patent/IL291639A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021105002A5 (https=) | ||
| US20190292135A1 (en) | Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders | |
| US11912680B2 (en) | Nitric oxide releasing prodrugs of MDA and MDMA | |
| Pitsch et al. | Anti-epileptogenic and anti-convulsive effects of fingolimod in experimental temporal lobe epilepsy | |
| CN114072396A (zh) | 作为dna-pk抑制剂的喹啉和噌啉衍生物 | |
| CN110035749B (zh) | Fabp4作为皮肤病中的治疗靶 | |
| JP2015536132A5 (https=) | ||
| JP2015520143A5 (https=) | ||
| CN110840870A (zh) | 选择性雄激素受体调节剂在治疗转移性和难治性乳癌中的应用 | |
| MX375082B (es) | Tratamiento o prevención de eventos cardiovasculares mediante la administración de un derivado de colchicina. | |
| JP7184241B2 (ja) | ベンズヒドリルチオアセトアミド化合物を有効成分として含む線維化疾患の治療用組成物 | |
| BR112020012629A2 (pt) | estimulantes de sgc | |
| JP2022550072A5 (https=) | ||
| JP2019519593A5 (https=) | ||
| JP2023524504A5 (https=) | ||
| JP2018150239A (ja) | β２ＧＰＩ遺伝子発現抑制ＲＮＡｉ医薬組成物 | |
| CN103200943A (zh) | 2-甲酰胺环氨基尿素衍生物在治疗egfr依赖性疾病或对靶向egfr家族成员的药剂有获得性耐受性的疾病中的应用 | |
| JP2021506958A (ja) | Ｅｇｆｒ阻害に関連する疾患を予防又は治療する方法 | |
| RU2005125919A (ru) | Альфа-аминоамидные производные, применимые в качестве антимигренозных средств | |
| JP2022510587A5 (https=) | ||
| JP2023518208A5 (https=) | ||
| JP2014523426A5 (https=) | ||
| JP2007530703A5 (https=) | ||
| CN115884789A (zh) | Pi4k抑制剂的抗冠状病毒效果以及应用 | |
| JP2007536262A5 (https=) |